Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-10-21 2023-03-16 172351
APO-MIRTAZAPINE 30MG TABLET Resolved 2022-12-09 2023-01-06 177603
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-09 2023-03-16 177606
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-03-16 178751
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178784
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178787
APO-CINACALCET 30MG TABLET Resolved 2023-01-13 2023-01-26 181113
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-01-20 2023-01-26 181970
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-09 2023-03-16 184089
APO-MIRTAZAPINE 30MG TABLET Resolved 2023-04-14 2023-08-04 189644
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-06 2023-05-26 191877
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-19 2023-06-09 192796
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-07 2023-09-15 197879
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-PAROXETINE 30MG TABLET Resolved 2023-09-22 2023-10-06 205018
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-06 2024-01-05 206560
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-27 2024-01-05 208417
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-11-06 2023-11-24 209348

Showing 1881 to 1900 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497

Showing 321 to 340 of 356